The latest price trends and purchase channels of brigatinib/brigatinib

Brigatinib/Brigatinib (Brigatinib) is an ALK-targeted drug, mainly used to treat patients with ALK-positive non-small cell lung cancer. As a second-generation ALK inhibitor, it has shown good efficacy in patients who are resistant to crizotinib treatment and can effectively delay disease progression. Compared with other similar drugs, one of the major advantages of brigatinib is its ability to control central nervous system metastasis, which provides a new solution to the common clinical problem of brain metastasis. In addition, brigatinib can also be used as an initial treatment drug, providing an additional option for patients with ALK mutations.

In China, the original drug brigatinib has been officially launched in recent years and has been included in the Class B medical insurance catalog. The specifications available on the market are relatively diverse, such as 30mg 14 tablets and 2 boards, 90mg 7 or 28 tablets, 180mg 7 tablets 4 boards, etc. Its price is still at a relatively high level, with a single box often costing around 10,000 yuan. However, the implementation of medical insurance policies has greatly reduced the proportion of patients paying out-of-pocket, making this drug significantly more accessible. In some provinces and cities, after medical insurance reimbursement, patients' financial burden has been greatly reduced, increasing the possibility of long-term treatment.

In addition to domestic original drugs, there are also cost-effective versions of generic drugs in overseas markets. For example, the generic version of brigatinib produced by a Lao pharmaceutical factory is priced at about RMB 500 for a package of 30 90 mg tablets, which has more economic advantages than the original drug. Although generic drugs are basically the same as the original drugs in terms of drug ingredients and mechanism of action, patients need to be extra cautious when choosing channels and ensure that they are obtained through formal channels to ensure the quality and safety of the drugs.

In terms of purchasing channels, patients can purchase the original brigatinib drug through regular tertiary hospital pharmacies or state-approved drug retail platforms, which is the safest and most reliable way. If you consider overseas generic drugs, use a legally qualified cross-border pharmacy or international drug supply organization to avoid affecting the efficacy due to unknown sources of drugs.

Reference materials:https://www.alunbrig.com/